The Plasma Protein Therapeutics Association (PPTA) is a dynamic trade association that represents a unique sector of the biologics and biotechnology industry.
PPTA represents more than 500 human plasma collection centers in the North America and Europe, as well as, the manufacturers of life-saving plasma protein therapies.
Our members produce approximately 80 percent of the plasma protein therapies in the U.S. and 60 percent of those manufactured in Europe.
PPTA works globally to:
- Advocate for access to and affordability of therapies for patients
- Engage in constructive dialogue with regulatory agencies
- Collaborate with more than 20 patient advocacy organizations
PPTA also administers standards programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients.
PPTA Proudly Supports World Hemophilia Day 2017 +
Register now for the 2017 Plasma Protein Forum! +
The 2017 Plasma Protein Forum will be held Tuesday, June 13 - Wednesday, June 14 at the Washington Marriott Georgetown in Washington, D.C.
Registration for the Forum includes access to all general sessions, the exhibit hall and all Forum breaks (you must be registered in order to participate in any of the Forum activities).Read More
The Hilfenhaus Award conferred to Prof. Farkas at the IPPC 2017 +
The 2017 Hilfenhaus Award was bestowed to Professor Henriette Farkas, MD, Ph.D., DSc, during IPPC 2017 for her work related to treating those suffering from Hereditary Angioedema (HAE) and working to improve treatments and patients’ quality of life. She is professor of allergology and clinical immunology at the Hungarian Angioedema Center at Semmelweis University in Budapest, Hungary.Read More